Have a website account?
Log In
or
Register
for exclusive website content.
Subscribe
Advanced Search
Home
Journal Info
About
atm
Indexing
Editors-in-Chief
Editorial Board
Authors
Former Editorial Board
Peer Review Process
Supplements and Series
Advertising Policy
Testimonials
For Authors
Author Instructions
Online Submission
Submit Multimedia Files
Reference Style
AME Editing Service
Interviews with Outstanding Authors
For Reviewers
Guidelines for Reviewers
Online Review
Reviewers
Ethics and Policies
Journal Management (Editorial Roles)
Editorial Policies
Publication Ethics Policy
Research Ethics Policy
Human and Animal Rights
Authorship and Contributorship
Informed Consent Policy
Conflicts of Interest
Data Sharing Policy
Open Access Statement
Content Licensing
Copyright and Permission
Quality Control System
Data and Reproducibility
Policy of Screening for Plagiarism Process
Policy of Dealing with Allegations of Research Misconduct
Corrections and Retractions
Complaints and Appeals
Special Contents
Special Series (Published)
Special Series (Ongoing)
Sharp Minds in China-CAS and CAE
Insights From the Reporting Guidelines
Archives
Online First
Article-Processing Charges
News
Home
/
Vol 8, No 7 (April 16, 2020)
/
Potential of combination therapy in EGFR mutated lung cancer
Letter to the Editor
Potential of combination therapy in EGFR mutated lung cancer
Makoto Maemondo
Article Options
PDF
423 views
Full Text
1363 views
COI Form
189 views
Download Citation
Bibtex
EndNote
ProCite
refMan
refWorks
Share
Share on Facebook
Share on Twitter
